{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:41:09Z","timestamp":1792528869642,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM103310"],"award-info":[{"award-number":["GM103310"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SF349247"],"award-info":[{"award-number":["SF349247"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celrep.2026.117914","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:36:53Z","timestamp":1788377813000},"page":"117914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV-1 antibody-mediated neutralization via a dual-glycan clamp"],"prefix":"10.1016","volume":"45","author":[{"given":"Jason","family":"Gorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid B.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Nazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijy","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsiana","family":"Bylund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renguang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ambrozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Doria-Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7123-4902","authenticated-orcid":false,"given":"Rosemarie D.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117914_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.2986290","article-title":"Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III","volume":"228","author":"Allan","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117914_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G","volume":"165","author":"Stewart-Jones","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117914_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117914_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/nature05818","article-title":"Exploiting the defensive sugars of HIV-1 for drug and vaccine design","volume":"446","author":"Scanlan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117914_bib5","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"Doores","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117914_bib6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","article-title":"Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers","volume":"11","author":"Pritchard","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117914_bib7","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/pr300870t","article-title":"Characterization of host-cell line specific glycosylation profiles of early transmitted\/founder HIV-1 gp120 envelope proteins","volume":"12","author":"Go","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.celrep.2026.117914_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023521","article-title":"The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade","volume":"6","author":"Bonomelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117914_bib9","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","article-title":"Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells","volume":"265","author":"Leonard","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117914_bib10","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1021\/bi000432m","article-title":"Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells","volume":"39","author":"Zhu","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2026.117914_bib11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/bioinformatics\/btab791","article-title":"GLYCO: a tool to quantify glycan shielding of glycosylated proteins","volume":"38","author":"Lee","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117914_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117914_bib13","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","author":"Bonsignori","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117914_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2014.09.009","article-title":"Structural evolution of glycan recognition by a family of potent HIV antibodies","volume":"159","author":"Garces","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117914_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.immuni.2015.10.014","article-title":"Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design","volume":"43","author":"Andrabi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117914_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01791-15","article-title":"New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency","volume":"90","author":"Doria-Rose","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.immuni.2015.11.007","article-title":"Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans","volume":"43","author":"Garces","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117914_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nsmb.3144","article-title":"Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design","volume":"23","author":"Gorman","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117914_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7514","article-title":"Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies","volume":"9","author":"Bonsignori","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117914_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41467-018-03565-6","article-title":"HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope","volume":"9","author":"Fera","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117914_bib22","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"Calarese","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117914_bib23","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1128\/JVI.01110-10","article-title":"Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged","volume":"84","author":"Doores","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib24","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.1128\/JVI.01229-14","article-title":"Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy","volume":"88","author":"Murin","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib25","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/jvi.76.14.7306-7321.2002","article-title":"The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha12 mannose residues on the outer face of gp120","volume":"76","author":"Scanlan","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.str.2018.10.007","article-title":"Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition","volume":"27","author":"Chuang","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2026.117914_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nsb0695-433","article-title":"A Trojan horse with a sweet tooth","volume":"2","author":"Wilson","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117914_bib28","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.cell.2021.04.042","article-title":"Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies","volume":"184","author":"Williams","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117914_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.1233989","article-title":"Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization","volume":"340","author":"Georgiev","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117914_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"Zhou","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117914_bib31","doi-asserted-by":"crossref","first-page":"E2083","DOI":"10.1073\/pnas.1208984109","article-title":"Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120","volume":"109","author":"West","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117914_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107831","article-title":"Landscape of Non-canonical Cysteines in Human V(H) Repertoire Revealed by Immunogenetic Analysis","volume":"31","author":"Prabakaran","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117914_bib33","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gkt1043","article-title":"SAbDab: the structural antibody database","volume":"42","author":"Dunbar","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117914_bib34","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.celrep.2017.02.003","article-title":"Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates","volume":"18","author":"Saunders","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117914_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.immuni.2017.03.017","article-title":"A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic beta-Hairpin Structure","volume":"46","author":"Lee","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117914_bib36","first-page":"7920","article-title":"Immunization against endogenous retroviral tumor-associated antigens","volume":"61","author":"Kershaw","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117914_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117914_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117914_bib39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","article-title":"EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy","volume":"12","author":"Barad","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117914_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1107\/S0909049503024130","article-title":"Recent developments in the PHENIX software for automated crystallographic structure determination","volume":"11","author":"Adams","year":"2004","journal-title":"J. Synchrotron Radiat."},{"key":"10.1016\/j.celrep.2026.117914_bib41","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117914_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1107\/S2059798318002425","article-title":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps","volume":"74","author":"Croll","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117914_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2026.117914_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117914_bib45","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables","volume":"84","author":"Doria-Rose","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cy0934s53","article-title":"Amine-reactive dyes for dead cell discrimination in fixed samples","author":"Perfetto","year":"2010","journal-title":"Curr Protoc Cytom."},{"key":"10.1016\/j.celrep.2026.117914_bib47","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib48","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/nprot.2013.117","article-title":"Isolation of human monoclonal antibodies from peripheral blood B cells","volume":"8","author":"Huang","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2026.117914_bib49","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1128\/JVI.01012-16","article-title":"Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding","volume":"90","author":"Longo","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117914_bib50","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2019.09.007","article-title":"Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields","volume":"51","author":"Gorman","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117914_bib51","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.vaccine.2021.04.063","article-title":"A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation","volume":"39","author":"Gulla","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117914_bib52","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.celrep.2018.01.023","article-title":"Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody","volume":"22","author":"Kwon","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117914_bib53","doi-asserted-by":"crossref","first-page":"W615","DOI":"10.1093\/nar\/gkh398","article-title":"MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes","volume":"32","author":"Davis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117914_bib54","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726009927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726009927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:34:40Z","timestamp":1792528480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726009927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211124726009927"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117914","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 antibody-mediated neutralization via a dual-glycan clamp","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117914"}}